Type 2 Diabetes Remission and Substantial Body Weight Reduction Achieved with Metformin and a Sodium-Glucose Cotransporter 2 Inhibitor

The overall goal in the treatment of type 2 diabetes mellitus (T2DM) is remission. However, the effects of a sodium-glucose cotransporter 2 inhibitor (SGLT2i) on remission of T2DM are unknown. We herein report a case involving an overweight 43-year-old man who completely recovered from T2DM after SG...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, Seigo, Jinnouchi, Hideaki, Hieshima, Kunio, Kurinami, Noboru, Jinnouchi, Katsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051125/
https://www.ncbi.nlm.nih.gov/pubmed/32175210
http://dx.doi.org/10.7759/cureus.7110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051125/
https://www.ncbi.nlm.nih.gov/pubmed/32175210
http://dx.doi.org/10.7759/cureus.7110

Ejemplares similares